Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

COGNEX

TACRINE HYDROCHLORIDE

Standard Dose
EQ 10MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview COGNEX is listed in Drugs@FDA under application 020070 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient TACRINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 10MG BASE Sponsor SHIONOGI INC Submission history Latest submission status date: 2003-06-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview COGNEX is listed in Drugs@FDA under application 020070 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient TACRINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 10MG BASE Sponsor SHIONOGI INC Submission history Latest submission status date: 2003-06-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.